• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过固相金属辅助裂解制备无载体添加的锝-99m配合物。

Preparation of no-carrier-added technetium-99m complexes via metal-assisted cleavage from a solid phase.

作者信息

Mundwiler Stefan, Candreia Lukas, Häfliger Pascal, Ortner Kirstin, Alberto Roger

机构信息

Department of Inorganic Chemistry, University of Zürich, CH-8057 Zürich, Switzerland.

出版信息

Bioconjug Chem. 2004 Jan-Feb;15(1):195-202. doi: 10.1021/bc034171f.

DOI:10.1021/bc034171f
PMID:14733600
Abstract

A novel method for the preparation of no-carrier-added (nca) complexes [99mTc(CO)3L] (L = diethylenetriamine or picolylamine-N-acetic acid) is described. The ligands were covalently bound to a solid support of organic polymers via formation of a tertiary amine from the chelating unit. This C-N bond to the solid phase is selectively cleaved during the formation of the technetium complexes by intramolecular nucleophilic attack of a remaining hydroxy ligand to the alpha-carbon. The complex [99mTc(CO)3L] is released into solution while uncomplexed ligand and uncleaved complex remain solid-phase bound. High specific activity technetium complexes can then be isolated by simple filtration. Cleavage yield depends on temperature, pH, and ligand. Up to 50% release from the solid phase could be achieved under optimized conditions. Corresponding to the 99mTc concentration, free ligand is present in concentrations lower than 10(-7) M. If a targeting vector is conjugated to these ligands, no-carrier-added radiopharmaceuticals can be prepared in that way.

摘要

描述了一种制备无载体添加(nca)配合物[99mTc(CO)3L](L = 二乙烯三胺或吡啶甲胺-N-乙酸)的新方法。通过螯合单元形成叔胺,使配体与有机聚合物的固体载体共价结合。在锝配合物形成过程中,剩余羟基配体对α-碳进行分子内亲核攻击,从而选择性地切断与固相的C-N键。配合物[99mTc(CO)3L]释放到溶液中,而未络合的配体和未切断的配合物仍与固相结合。然后通过简单过滤即可分离出高比活度的锝配合物。切断产率取决于温度、pH值和配体。在优化条件下,固相释放率可达50%。与99mTc浓度相对应,游离配体的浓度低于10^(-7) M。如果将靶向载体与这些配体偶联,就可以用这种方法制备无载体添加的放射性药物。

相似文献

1
Preparation of no-carrier-added technetium-99m complexes via metal-assisted cleavage from a solid phase.通过固相金属辅助裂解制备无载体添加的锝-99m配合物。
Bioconjug Chem. 2004 Jan-Feb;15(1):195-202. doi: 10.1021/bc034171f.
2
A new strategy for the preparation of peptide-targeted technetium and rhenium radiopharmaceuticals. The automated solid-phase synthesis, characterization, labeling, and screening of a peptide-ligand library targeted at the formyl peptide receptor.一种制备肽靶向锝和铼放射性药物的新策略。针对甲酰肽受体的肽配体库的自动化固相合成、表征、标记及筛选。
Bioconjug Chem. 2005 Sep-Oct;16(5):1189-95. doi: 10.1021/bc0500591.
3
A solid-phase labeling strategy for the preparation of technetium and rhenium bifunctional chelate complexes and associated peptide conjugates.一种用于制备锝和铼双功能螯合物复合物及相关肽缀合物的固相标记策略。
Bioconjug Chem. 2006 Jan-Feb;17(1):226-35. doi: 10.1021/bc050216w.
4
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules.含二硫醇盐和氨基二膦的中性氮合锝(V)混合配体配合物的合成、表征及生物学评价。一种将锝与生物分子连接的新体系。
Bioconjug Chem. 2004 May-Jun;15(3):628-37. doi: 10.1021/bc0499782.
5
Synthesis and characterization of novel oxotechnetium (99Tc and 99mTc) and oxorhenium complexes from the 2,2'-bipyridine (NN)/thiol (S) mixed-ligand system.基于2,2'-联吡啶(NN)/硫醇(S)混合配体体系的新型锝(99Tc和99mTc)及铼氧配合物的合成与表征
Inorg Chem. 2003 Sep 8;42(18):5778-84. doi: 10.1021/ic034368j.
6
Syntheses and characterization of dicarbonyl-nitrosyl complexes of technetium(I) and rhenium(I) in aqueous media: spectroscopic, structural, and DFT analyses.锝(I)和铼(I)的二羰基-亚硝酰配合物在水介质中的合成与表征:光谱、结构和密度泛函理论分析
Inorg Chem. 2005 Feb 7;44(3):683-90. doi: 10.1021/ic049599k.
7
fac-Re(CO)3L complexes containing tridentate monoanionic ligands (L-) with a seldom-studied sulfonamido group as one terminal ligating group.含有三齿单阴离子配体(L-)的fac-Re(CO)₃L配合物,其中磺酰胺基作为一个末端连接基团,该基团很少被研究。
Inorg Chem. 2007 Aug 20;46(17):6942-9. doi: 10.1021/ic700594a. Epub 2007 Jul 26.
8
A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands.一种新型三元配体体系,用于以含亚胺氮杂环作为共配体对肼基烟酰胺修饰的生物活性分子进行99mTc标记。
Bioconjug Chem. 1998 Sep-Oct;9(5):583-95. doi: 10.1021/bc9800116.
9
Rhenium and technetium tricarbonyl complexes anchored by pyrazole-based tripods: novel lead structures for the design of myocardial imaging agents.由吡唑基三脚架锚定的铼和锝三羰基配合物:用于设计心肌显像剂的新型先导结构。
Dalton Trans. 2007 Jul 28(28):3010-9. doi: 10.1039/b705226j. Epub 2007 Jun 6.
10
Aqueous fluoride and the preparation of [99mTc(CO)3(OH2)3]+ and 99mTc-carborane complexes.水性氟化物以及[99mTc(CO)3(OH2)3]+和99mTc-碳硼烷配合物的制备。
Inorg Chem. 2005 Dec 12;44(25):9585-91. doi: 10.1021/ic051123t.

引用本文的文献

1
Synthesis, spectroscopic analysis and crystal structure of (-{2-[(2-amino-eth-yl)amino]-eth-yl}-4'-methyl-[1,1'-biphenyl]-4-sulfonamidato)tri-carb-on-ylrhenium(I).(-{2-[(2-氨基-乙基)氨基]-乙基}-4'-甲基-[1,1'-联苯]-4-磺酰胺基)三羰基铼(I)的合成、光谱分析及晶体结构
Acta Crystallogr E Crystallogr Commun. 2024 Jun 18;80(Pt 7):742-745. doi: 10.1107/S2056989024005656. eCollection 2024 Jun 1.
2
Synthesis of -Symmetric Dimeric Re(I) Peptide Complexes.-对称二聚体铼(I)肽配合物的合成
Eur J Inorg Chem. 2013 Mar 1;2013(8):1265-1268. doi: 10.1002/ejic.201201444.
3
Coordination modes of multidentate ligands in fac-[Re(CO)(3)(polyaminocarboxylate)] analogues of (99m)Tc radiopharmaceuticals. dependence on aqueous solution reaction conditions.
多核配合物[Re(CO)3(polyaminocarboxylate)]类似物(99mTc 放射性药物)中多齿配体的配位方式。对水溶液反应条件的依赖性。
Inorg Chem. 2010 Apr 5;49(7):3141-51. doi: 10.1021/ic9017568.
4
99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor.对胃泌素释放肽(GRP)受体具有高亲和力的99mTc(CO)3 - DTMA 蛙皮素缀合物。
Nucl Med Biol. 2008 Apr;35(3):263-72. doi: 10.1016/j.nucmedbio.2007.11.007.
5
First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.首次对一种99mTc-三羰基配合物99mTc(CO)3(LAN)作为新型肾放射性药物在人体中的应用进行评估。
J Nucl Med. 2006 Jun;47(6):1032-40.